Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesised reference material for the support of LC-MS/MS-based drug testing

Analytical and Bioanalytical Chemistry

Volumn 401, Issue 2, 2011, Pages 493-505

  Beuck, Simon ^a   Möller, Ines ^a   Thomas, Andreas ^a   Klose, Annika ^a,b   Schlörer, Nils ^c   Schänzer, Wilhelm ^a   Thevis, Mario ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

CID; Ion molecule reaction; JWH 018; Metabolite structure; Spice; Synthetic cannabinoids

Indexed keywords

ANALYTES; ANALYTICAL APPLICATIONS; CHARACTERISATION; CHEMICAL SYNTHESIS; CHROMATOGRAPHIC SEPARATIONS; CID; COLLISION-INDUCED DISSOCIATION; DOPING CONTROL; DRUG TESTING; GASPHASE; HIGH RESOLUTION; IN-VIVO; ION-MOLECULE REACTION; JWH-018; LC-MS/MS; METABOLIC REACTIONS; NEUTRAL LOSS; ORBITRAP; PHASE I; PROTONATED COMPOUNDS; REFERENCE MATERIAL; REFERENCE STANDARD; SCREENING PROCEDURES; STRUCTURAL ASSIGNMENTS; SYNTHETIC CANNABINOID; SYNTHETIC CANNABINOIDS; TANDEM MASS SPECTROMETRY; TARGET ANALYTES; URINARY MARKERS; URINARY METABOLITES; URINE SAMPLE;

BIOMOLECULES; BODY FLUIDS; DISSOCIATION; ELECTROSPRAY IONIZATION; ISOTOPES; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITES; NAPHTHALENE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RESONANCE; SPECTROMETERS; SYNTHESIS (CHEMICAL);

METABOLISM;

1 PENTYL 3 (1 NAPHTHOYL)INDOLE; 1-PENTYL-3-(1-NAPHTHOYL)INDOLE; INDOLE DERIVATIVE; NAPHTHALENE DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DOPING; HUMAN; LIQUID CHROMATOGRAPHY; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE; TANDEM MASS SPECTROMETRY; URINE;

CHROMATOGRAPHY, LIQUID; DOPING IN SPORTS; HUMANS; INDOLES; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; NAPHTHALENES; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY;

EID: 79960562678     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-011-4931-5     Document Type: Article

References (21)

1. Steup C (2008) Untersuchung des Handelsproduktes "Spice". THC PHARM GmbH
2. V Auwärter S Dresen W Weinmann M Müller M Pütz N Ferreirós 2009 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom 44 5 832 837 10.1002/jms.1558
3. EMCDDA (2009) EMCDDA 2009 Thematic paper-Understanding the 'Spice' phenomenon. Office for Official Publications of the European Communities. http://www.emcdda.europa.eu/publications/thematic-papers/spice. Accessed January 2010
4. WADA (2010) The 2010 prohibited list. WADA (World Anti-Doping Agency). http://www.wada-ama.org/rtecontent/document/2010-Prohibited-List-FINAL-EN-Web. pdf. Accessed January 2010
5. MA Neukamm TE Murdter C Knabbe H-D Wehner F Wehner 2009 Quantitative detection of the active "Spice" ingredient JWH-018 in serum by means of liquid chromatography-tandem mass spectrometry Blutalkohol 46 6 373 379 1:CAS:528:DC%2BD1MXhsF2qurzJ
6. J Teske JP Weller A Fieguth T Rothamel Y Schulz HD Troger 2010 Sensitive and rapid quantification of the cannabinoid receptor agonist naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in human serum by liquid chromatography-tandem mass spectrometry J Chromatogr B Analyt Technol Biomed Life Sci 878 27 2659 2663 10.1016/j.jchromb.2010.03.016 1:CAS:528: DC%2BC3cXhtFyns7jK
7. A Wintermeyer I Möller M Thevis M Jübner J Beike MA Rothschild K Bender 2010 In vitro phase I metabolism of the synthetic cannabimimetic JWH-018 Anal Bioanal Chem 398 5 2141 2153 10.1007/s00216-010-4171-0 1:CAS:528:DC%2BC3cXhtFCqsrbI
8. T Sobolevsky I Prasolov G Rodchenkov 2010 Detection of JWH-018 metabolites in smoking mixture post-administration urine Forensic Sci Int 200 1-3 141 147 10.1016/j.forsciint.2010.04.003 1:CAS:528:DC%2BC3cXotVagsbo%3D
9. Möller I, Wintermeyer A, Bender K, Jübner M, Thomas A, Krug O, Schänzer W, Thevis M (2011) Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls. Drug Test Anal. doi: 10.1002/dta.158
10. Makriyannis A, Deng H (2005) Cannabimimetic indole derivatives. US 6900236 B1
11. M Thevis H Geyer U Mareck W Schänzer 2005 Screening for unknown synthetic steroids in human urine by liquid chromatography-tandem mass spectrometry J Mass Spectrom 40 7 955 962 10.1002/jms.873 1:CAS:528: DC%2BD2MXnvF2ltLw%3D (Pubitemid 41098082)
12. W Dünges 1973 Alkylation of acidic organic compounds for gas chromatographic analysis Chromatographia 6 4 196 197 10.1007/BF02269193
13. ICH (2005) Validation of analytical procedures: text and methodology Q2(R1). ICH (International Conference on Harmonization). http://www.ich.org/LOB/ media/MEDIA417.pdf. Accessed January 2010
14. R Dams MA Huestis WE Lambert CM Murphy 2003 Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: influence of ionization type, sample preparation, and biofluid J Am Soc Mass Spectrom 14 11 1290 1294 10.1016/S1044-0305(03)00574-9 1:CAS:528:DC%2BD3sXosVWqsbs%3D (Pubitemid 37330133)
15. BK Matuszewski ML Constanzer CM Chavez-Eng 2003 Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS Anal Chem 75 13 3019 3030 10.1021/ac020361s 1:CAS:528: DC%2BD3sXltV2jsL8%3D (Pubitemid 36830428)
16. S Beuck T Schwabe S Grimme N Schlörer M Kamber W Schänzer M Thevis 2009 Unusual mass spectrometric dissociation pathway of protonated isoquinoline-3-carboxamides due to multiple reversible water adduct formation in the gas phase J Am Soc Mass Spectrom 20 11 2034 2048 10.1016/j.jasms.2009.07. 016 1:CAS:528:DC%2BD1MXht1ylsb%2FK
17. M Thevis M Kohler N Schlörer W Schänzer 2008 Gas phase reaction of substituted isoquinolines to carboxylic acids in ion trap and triple quadrupole mass spectrometers after electrospray ionization and collision-induced dissociation J Am Soc Mass Spectrom 19 1 151 158 10.1016/j.jasms.2007.11.003 1:CAS:528:DC%2BD1cXosFKluw%3D%3D
18. J Laakia A Adamov M Jussila CS Pedersen AA Sysoev T Kotiaho 2010 Separation of different ion structures in atmospheric pressure photoionization-ion mobility spectrometry-mass spectrometry (APPI-IMS-MS) J Am Soc Mass Spectrom 21 9 1565 1572 10.1016/j.jasms.2010.04.018 1:CAS:528:DC%2BC3cXhtVKiurrI
19. WADA (2004) Adverse analytical findings reported by accredited laboratories. WADA (World Anti-Doping Agency). http://www.wada-ama.org/ rtecontent/document/criteria-1-2.pdf. Accessed January 2010
20. Mandel J (1964) The statistical analysis of experimental data. Interscience, New York
21. FDA (2001) Guidance for industry bioanalytical method validation. FDA (U.S. Food and Drug Administration). http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm070107.pdf. Accessed January 2010